Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.37 is 30% above its 3-year average of 1.05, near the high end of its 3-year range (0.00–1.71).
As of the fiscal period ended Tuesday, March 31, 2026. 11.18% below its 12-month average of 1.54.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-03-31): 1.37.
CURRENT RATIO
1.37
CURRENT RATIO AVG TTM
1.54
CURRENT RATIO AVG 3Y
1.22
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-11.18%
CURRENT VS 3Y AVG
+11.70%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
-63.69%
vs the sector median at left
WORK Medical Technology Group Ltd. Class A
Market Cap
$3.63M
Current Ratio
1.37
TTM Avg
1.54
3Y Avg
1.22
5Y Avg
N/A
Market Cap
$3.53M
Current Ratio
3.73
TTM Avg
3.25
3Y Avg
4.33
5Y Avg
4.33
Market Cap
$3.90M
Current Ratio
2.32
TTM Avg
2.96
3Y Avg
2.13
5Y Avg
2.01
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| WORK Medical Technology Group Ltd. Class A (WOK) | $3.63M | 1.37 | 1.54 | 1.22 | N/A |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.65M | 2.01 | 0.91 | 1.26 | 1.78 |
| Evogene Ltd. (EVGN)vs › | $3.65M | 3.57 | 2.84 | 4.34 | 5.17 |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.53M | 3.73 | 3.25 | 4.33 | 4.33 |
| Moolec Science S.A. (MLEC)vs › | $3.50M | 0.15 | 0.91 | 0.63 | 0.64 |
| Eocene Ltd. (EOCN)vs › | $3.50M | N/A | N/A | N/A | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 1.97 | 1.45 | 2.21 | 4.94 |
| 60 Degrees Pharmaceuticals, Inc. (SXTP)vs › | $3.90M | 2.32 | 2.96 | 2.13 | 2.01 |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.93M | 2.08 | 2.77 | 2.83 | 2.68 |
| Nexalin Technology, Inc. (NXL)vs › | $3.30M | 1.25 | 6.05 | 6.00 | 4.06 |
Current Ratio
1.37
Quick Ratio
0.82
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-03-31 | 1.37 |
| 2025-09-30 | 1.71 |
| 2025-03-29 | 1.14 |
| 2024-09-29 | 1.03 |
| 2024-03-29 | 0.92 |
| 2023-09-29 | 1.17 |
| 2023-03-29 | 0.00 |
